Navigation Links
Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site

RALEIGH, N.C., May 22, 2013 /PRNewswire/ -- STEPh, Inc., a full service medical communications company, is pleased to announce the launch of their web site ( ) dedicated to investigational drug reports [STEPh Reports]. 

About STEPh Reports

STEPh Reports are comprehensive critical reviews of drugs in development. 

Each STEPh Report assesses the competitive landscape by individual drug monograph, MOA, clinical trials data, projected launch year, company, and specific key issues.  STEPh Reports are written by individuals with expertise in clinical pharmacology and knowledge of drug development processes.  Reports are reviewed by subject matter experts.  STEPh Reports are updated quarterly and are fully referenced, including links to original source documents.  Complementary features to STEPh Reports include daily and archival news services, pipeline tables, mini reviews of Hot Topics, and links to key resources.  A Q&A service is also available upon request.

STEPh Reports are available for purchase by yearly subscription to the web site.  The service is available also to individuals and sponsors at a nominal charge. 

Other Services Offered by STEPh, Inc.

Medical Writing—manuscripts, abstracts, posters, product monographs, training materials.  STEPh, Inc., has an impeccable track record for manuscript acceptance in peer review journals, and has developed Product Monographs and learning systems to support new product launches.

Medical Information—creation of standard response letters, support for product launches.  The President of STEPh, Inc., Dr. Bauman, is a founding member of the Medical Communications subgroup of DIA and has been a Medical Information practitioner for over 30 years.  He supervised the medical information support for numerous new product launches and coordinated international medical information services.

Competitive Intelligence (CI)—investigational drug reports, individualized primary research, meetings coverage.  The principals at STEPh, Inc., are notable leaders in CI and have practiced this discipline for more than 20 years. 

About STEPh, Inc.

STEPh, Inc., was formed in 2005 by pharmaceutical industry veterans, each with more than 20 years' experience in Medical Affairs departments of large pharma and biotech companies.  Dr. Jay Bauman is former Editor of Hospital Edition of US Pharmacist, invited speaker at SCIP meetings, and accomplished author with more than 30 technical publications.


Further information about pricing for services can be obtained by contacting STEPh, Inc., as noted below:

Dr. Jay H. Bauman

President, STEPh, Inc.

919-818-4942 (cell)


SOURCE Scientific and Technical Evaluation of Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting
2. Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
3. Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress
4. Boston Scientific Schedule of Major Events and Presentations at Heart Rhythm 2013
5. Kewaunee Scientific Announces CEO Retirement and Appointment of Successor
6. Blue Belt Technologies Announces Formation of Hip Scientific Advisory Board for Development of Next NavioPFS Application for Femoroacetabular Impingement
7. Afraxis Appoints Carmine Stengone President and Chief Executive Officer, and Christopher Rex, Ph.D., Chief Scientific Officer
8. SkelRegen Welcomes Director of Scientific Affairs to Management Team
9. MDA Scientific Conference To Focus On Therapy Development For Neuromuscular Diseases
10. What Will Thermo Fisher Scientific and Life Technologies $14 billion Merger hold for the Top Ten Suppliers of Synthetic Biology Technology and DNA Sequencing Landscape?
11. Kinex Pharmaceuticals Chief Scientific Officer, Dr. David Hangauer, named the American Cancer Societys 2013 Honoree for its Cuisine for a Cure event
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 3D ... by 2022, according to a new report by Grand View ... Kidney Disease (CKD) which demands kidney transplantation is expected to ... cost effective substitute for organ transplantation. --> 3D ... by 2022, according to a new report by Grand View ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
(Date:11/26/2015)... November 26, 2015 ... adds "Global Repaglinide Industry ... Report on China Repaglinide Market, 2010-2019" ... data and information to its online ... . --> ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... 2015 , ... Beddit® has launched a new Android app for ... features a more intuitive SleepScore™ that rates sleep quality on a 100-point scale and ... created by a proprietary algorithm. Beddit analyzes the data to provide an easy to ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... In an ... Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of ... and surgical intensive care units (totaling 30 beds) from May 2014 through October 2015 ...
(Date:11/25/2015)... ... ... Today, Mothers Against Drunk Driving (MADD) learned that the number of ... time since 2011. In 2014, there were 9,967 fatalities involving an alcohol impaired driver, ... Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes in 2014. Drunk ...
(Date:11/25/2015)... Silver Spring, Md (PRWEB) , ... November 25, ... ... the Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups ... the history of this disease. The Periwinkle Pioneers, nominated by the public, will ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... announced that it has undertaken significant expansion of its current state of the ... is part of PharmaTech’s strategy to increase its manufacturing capacity as well as ...
Breaking Medicine News(10 mins):